Related references
Note: Only part of the references are listed.Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma
Hiroshi Kubota et al.
CELL STRESS & CHAPERONES (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Recent Advances in Hsp90 Inhibitors as Antitumor Agents
S. Messaoudi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells
Fumitaka Koga et al.
CELL CYCLE (2007)
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Alison Maloney et al.
CANCER RESEARCH (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α
XG Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer:: Role of free radical formation
M Quintero et al.
CANCER RESEARCH (2006)
Modulating molecular chaperone Hsp90 functions through reversible acetylation
S Aoyagi et al.
TRENDS IN CELL BIOLOGY (2005)
Accumulation and nuclear import of HIF1 alpha during high and low oxygen concentration in skeletal muscle cells in primary culture
HP Kubis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease
AJ Giaccia et al.
GENES & DEVELOPMENT (2004)
Antimetastatic activity of the photodynamic agent hypericin in the dark
M Blank et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1α/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol
E Hur et al.
MOLECULAR PHARMACOLOGY (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
Share Paper
